معرفی
Dr. Bob S. Carter is the Senior Vice President for Health Sciences and CEO of University of Utah Health. He holds a professorial role in the Department of Neurosurgery at the Spencer Fox Eccles School of Medicine. Previously, he served as the William and Elizabeth Sweet Endowed Professor in Neuroscience at Harvard Medical School and Neurosurgeon-In-Chief at Mass General Brigham. His expertise spans neuro-oncology, clinical neurosurgery, and translational research in brain tumors, including CAR T-cell therapy and exosome-based diagnostics. Dr. Carter received his MD and PhD in epidemiology from Johns Hopkins University and a BS in chemistry from Brigham Young University.
- Education:
- BS in Chemistry, Brigham Young University (1986)
- MD and PhD in Epidemiology, Johns Hopkins University (1992)
- Leadership Roles:
- Former Chair of Neurosurgery at UC San Diego School of Medicine
- Co-founder of Mass General Neuroscience
- Co-Director of the Moores Cancer Center Brain Tumor Program
Dr. Carter’s research focuses on glioblastoma, liquid biopsy, and leveraging big data in neurosurgical outcomes. He actively participates in NIH-funded grants and has contributed to over 18 years of academic research. His clinical interests include complex intracranial surgery, brain tumor management, and patient-centered care. Dr. Carter is committed to expanding healthcare access in Utah and advancing the University of Utah’s mission to improve societal health through innovation.
Awards:
- 2024 Elected Member, National Academy of Medicine
- America’s Top Doctors®
- Fellow, American Association of Neurological Surgeons
Future Initiatives: Dr. Carter leads projects such as the new Spencer Fox Eccles School of Medicine Building, West Valley City Hospital, and Huntsman Institute expansions. He emphasizes sustainable growth, clinical integration, and preventive population health strategies.